✦ LIBER ✦

P-053 Study on modulation of nm23-H1 expression by focal adhesionkinase in resected non-small cell lung cancer

✍ Scribed by Hsu, N.; Chow, K.

Book ID: 118572961
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 143 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80547-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic impact of nm23-H1 and PCNA ex

Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer

✍ Chengying Liu; Jun Liu; Xin Wang; Weidong Mao; Lian Jiang; Hua Ni; Mingcong Mo; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

## Abstract ## Introduction The purpose of this study was to evaluate the value of nm23‐H1 and proliferating cell nuclear antigen (PCNA) expression as well as other confirmed prognostic factors in predicting the clinical outcome after definitive surgery of pathologic stage I non‐small cell lung ca

Clinical relevance of neuroendocrine dif

Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases

✍ William Sterlacci; Michael Fiegl; Wolfgang Hilbe; Jutta Auberger; Gregor Mikuz; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 377 KB

P-649 Role of CEA, PLUNC and CK19 mRNA e

P-649 Role of CEA, PLUNC and CK19 mRNA expression in lymph nodes from resected stage I non-small cell lung cancer (NSCLC) patients as markers of occult micrometastasis: A pilot study

✍ Benlloch, S.; Galbis, J.; Alenda, C.; Peiró, E.; Rodriguez-Paniagua, J.; Sanchez 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Comment on “Survival improvement in rese

Comment on “Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature” by T. Berghmans, M. Paesmans, A.P. Meert, C. Mascaux, P. Lothaire, J.J. Lafitte, et al. [Lung Cancer 49 (2005) 13–23.]

✍ Pignon, Jean-Pierre; Burdett, S. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

1125 POSTER Improved disease-free durviv

1125 POSTER Improved disease-free durvival and dverall durvival by navelbine (N) and cisplatin (P) as adjuvant chemotherapy in completely resected (Stage I-III) Non Small Cell Lung Cancer (NSCLC): ANITA Trial. on behalf of adjuvant navelbine international trial associtation

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB